ARCHIVES

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

CCIRC Reviews Two Existing, One Prospective Cooperative Group

March 4, 1977

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

NCI, NHGRI plan $100-million, three-year feasibility test for cancer genome project. NCI to establish biospecimen office.

September 23, 2005

Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More

July 3, 1987

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997